Freeline Therapeutics Holdings plc Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2022.
  • Freeline Therapeutics Holdings plc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was $1.17M.
  • Freeline Therapeutics Holdings plc annual Net Income (Loss) Attributable to Parent for 2022 was -$89M, a 36.6% increase from 2021.
  • Freeline Therapeutics Holdings plc annual Net Income (Loss) Attributable to Parent for 2021 was -$140M, a 45.8% decline from 2020.
  • Freeline Therapeutics Holdings plc annual Net Income (Loss) Attributable to Parent for 2020 was -$96.3M, a 78.7% decline from 2019.
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$89M +$51.4M +36.6% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-04
2021 -$140M -$44.1M -45.8% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-04
2020 -$96.3M -$42.4M -78.7% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-04
2019 -$53.9M -$20.6M -62% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-31
2018 -$33.3M Jan 1, 2018 Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.